Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cancer Biother Radiopharm. 2013 Jul-Aug;28(6):466-70. doi: 10.1089/cbr.2012.1426. Epub 2013 Jun 8.

CD146 protein as a marker to predict postoperative liver metastasis in colorectal cancer.

Author information

  • 1Department of Neurology, First Affiliated Hospital of Liaoning Medical College, Jinzhou, China.

Abstract

OBJECTIVE:

To study the expression and regulatory effects of CD146 protein in colorectal cancer and the correlation between CD146 protein expression and the prognosis of colorectal cancer.

MATERIALS AND METHODS:

The CD146 protein level was detected by immunohistochemistry staining. The relationship between CD146 expression and clinicopathological parameters of colorectal cancer was determined.

RESULTS:

It was observed that 216 (20.00%) of the 1080 cases positively expressed CD146 protein. Univariate analyses indicated that CD146 expression was related to histological grade, Duke's stage, and liver metastasis (p=0.001, 0.001, and 0.001, respectively). Spearman correlation analysis showed that CD146 expression has line correlation to histological grade, Duke's stage, and liver metastasis (p=0.02, 0.01 and 0.001, respectively). After multivariate analysis, Duke's stage and CD146 were related to liver metastasis (p=0.01 and 0.001, respectively). In the Cox regression test, histological grade, Duke's stage, and CD146 were detected as the independent prognostic factors (p=0.045, 0.01, and 0.001, respectively).

CONCLUSIONS:

CD146 protein may be a potential biomarker for the postoperative liver metastasis of colorectal cancer.

PMID:
23745687
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Mary Ann Liebert, Inc.
    Loading ...
    Write to the Help Desk